STAT

DECEMBER 4, 2024

Also, compounding pharmacies fire back at Novo Nordisk for its assertion that GLP-1 drugs are too difficult to compound. Lots today on GLP-1s: First we see tirzepatide outperforming semaglutide in a head-to-head study in obesity. Also, a Michael Gilman company pivots and more. Read the rest…

Compounding Pharmacies 268

Compounding Pharmacies Compounding Drug Pricing Drug Development 268

STAT

OCTOBER 22, 2024

Novo Nordisk has asked the Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex for the pharmacies to safely make. The FDA still has to make a decision on whether to officially place semaglutide on the lists.

Compounding 361

Compounding Compounding Pharmacies Documentation Diabetes 361

STAT

OCTOBER 30, 2024

Over the past two years, patients seeking treatment have been turning to compounding pharmacies, which make cheaper copies of branded treatments and are legally allowed to do so only when the branded treatments are listed on the FDA’s shortage list.

Compounding Pharmacies 337

Compounding Pharmacies Compounding Diabetes 337

STAT

OCTOBER 11, 2024

The move was a clear warning to compounders that they can no longer make copycat versions of the drugs — a process that is only permitted when the medications are on an official agency shortage list. Read the rest…

Compounding 358

Compounding Diabetes 358

STAT

SEPTEMBER 20, 2023

As the gold rush over weight-loss drugs accelerates, Eli Lilly filed lawsuits against several compounding pharmacies, spas and wellness centers around the U.S. The drug company accused four compound pharmacies of violating state laws because those versions were not approved by the U.S.

Compounding 355

Compounding Compounding Pharmacies Diabetes 355

STAT

OCTOBER 8, 2024

A trade group representing large compounding pharmacies has sued the U.S. Food and Drug Administration for a “reckless and arbitrary” decision to remove a widely prescribed Eli Lilly drug for combating diabetes and obesity from an official shortages list.

Compounding 343

Compounding Compounding Pharmacies Diabetes Drug Pricing 343

STAT

OCTOBER 6, 2023

judge dismissed its lawsuit accusing a compound pharmacy of selling versions of its Wegovy and Ozempic medicines, which are widely prescribed for weight loss and have become franchise products for the drug company. The drug maker argued the compounders were selling versions of its medicines that were never approved by the U.S.

Compounding 290

Compounding Compounding Pharmacies 290

STAT

NOVEMBER 4, 2024

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so predictable routine of online meetings, phone calls, and deadlines has returned. But you knew this would happen, yes? The world, such as it is, continues to spin.

Compounding 268

Compounding Pharmaceutical Companies Pharmaceutical Companies 268

STAT

APRIL 25, 2025

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up. We expect to promenade with the official mascots and catch up on our reading, but are, otherwise, open to suggestion.

Compounding 209

Compounding 209

STAT

MARCH 5, 2025

Novo Nordisk will start selling its obesity drug Wegovy directly to patients at a reduced price, following a similar move from Eli Lilly as the two drugmakers compete for market share and try to draw patients away from compounding pharmacies that have been making cheaper copies of weight loss drugs.

Compounding Pharmacies 321

Compounding Pharmacies Compounding 321

STAT

NOVEMBER 30, 2023

Novo Nordisk filed lawsuits against two compounding pharmacies for selling adulterated and misbranded compounded drugs claiming to contain semaglutide, the active ingredient in Wegovy and Ozempic (see here and here ). Testing of compounded drugs from these pharmacies revealed unknown impurities up to 33%, the company claims.

Compounding 269

Compounding Compounding Pharmacies Chemotherapy 269

STAT

MAY 15, 2023

At the urging of the Alliance for Pharmacy Compounding, the trade association I lead, the Food and Drug Administration in April 2020 issued temporary guidance allowing traditional compounding pharmacies, within tight regulatory guardrails, to prepare 13 Covid drugs from pure ingredients to meet hospitals’ urgent need.

Compounding Pharmacies 246

Compounding Pharmacies Compounding Hospitals 246

STAT

SEPTEMBER 19, 2024

Hims & Hers Health plans to sell compounded versions of Novo Nordisk’s popular weight loss drug Wegovy to patients in certain professions for $99 a month , Reuters says. Compounded GLP-1 injections are fulfilled and shipped from Hims & Hers affiliated pharmacies and are regulated by the FDA.

Compounding 266

Compounding Compounding Pharmacies Packaging 266

STAT

OCTOBER 23, 2024

Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex for the pharmacies to safely make , STAT reports. Novo has repeatedly argued that compounded products are risky, stressing that they are not approved by the FDA.

Compounding 258

Compounding Compounding Pharmacies Biosimilars Documentation 258

STAT

DECEMBER 4, 2024

  A trade group for compounding pharmacies slammed an attempt by Novo Nordisk to convince the U.S. Food and Drug Administration that semaglutide — the key ingredient in its diabetes and obesity drugs — should be added to a list of medicines that are too difficult to compound.

Compounding 229

Compounding Compounding Pharmacies Diabetes Documentation 229

STAT

FEBRUARY 7, 2025

wrote that they worry that the Hims ad, which will be seen by millions of people during the big game on Sunday, “risks misleading patients by omitting any safety or side effect information” about the compounded weight loss drugs that it promotes. Dick Durbin (D-Ill.) and Roger Marshall (R-Kan.)

Compounding 251

Compounding 251

STAT

OCTOBER 12, 2022

Food and Drug Administration and a trade group that represents large compound pharmacies have resolved a long-running dispute over the use of bulk ingredients, clearing the way for some compounded medicines to become available more quickly. Continue to STAT+ to read the full story…

Compounding Pharmacies 246

Compounding Pharmacies Compounding 246

STAT

JULY 26, 2023

One of the largest compound pharmacy operations in the U.S. Yet the compounder failed to investigate the causes or take adequate corrective or preventive actions to mitigate the risk of formation. The Food and Drug Administration found several issues that raised the possibility of contamination during an inspection of an Allentown, Pa.,

Compounding 246

Compounding Hospitals Compounding Pharmacies 246

STAT

DECEMBER 20, 2024

The agency will give compounders a grace period of 60 to 90 days before enforcing rules that would put a halt to their work, in an effort to avoid disruption for patients. That should have prohibited compounders from continuing to make copies, because they can do so only when a treatment is on the shortage list.

Compounding 270

Compounding Diabetes 270

STAT

SEPTEMBER 13, 2024

I first met Jane (not her real name, of course) on a Friday afternoon in our clinic. She was referred for further evaluation of her chest pain, which, in the context of her family history of early-onset heart attacks and her morbid obesity, understandably concerned her primary care doctor.

Compounding 326

Compounding 326

STAT

JANUARY 7, 2025

 The plants’ inability to remove compounds known as organofluorines from wastewater before they enter drinking water supplies becomes even more pronounced during droughts and could affect up to 23 million people.    Most of the compounds came from commonly prescribed medications including antidepressants and statins.

Compounding 252

Compounding Documentation 252

STAT

AUGUST 10, 2023

In late May, the Food and Drug Administration said it received a “few” adverse event reports concerning compounded versions of the injectable medicines, which both contain the same active ingredient, known as semaglutide.

Compounding 246

Compounding Diabetes 246

STAT

SEPTEMBER 20, 2023

… As the gold rush over weight-loss drugs accelerates, Eli Lilly filed lawsuits against several compounding pharmacies, spas and wellness centers around the U.S. The drug company accused four compound pharmacies of violating state laws because those versions were not approved by the U.S.

Compounding 252

Compounding Compounding Pharmacies Diabetes 252

STAT

JANUARY 22, 2025

” Experts told STAT there’s been a surge of interest for these compounds from biotech and pharma in the last few months, spurred on most by the presentation of promising clinical data from Summit Therapeutics.

Immunity 360

Immunity Immunization Compounding Drug Development 360

STAT

MARCH 20, 2025

Food and Drug Administration wants bulk production of copycat versions of popular weight-loss drugs to stop, but telehealth companies and compounding pharmacies that have fueled widespread use of the knockoffs have other plans , The Wall Street Journal writes. And some pharmacies making the GLP-1 drug copycats will continue.

Compounding Pharmacies 269

Compounding Pharmacies Compounding Dosage 269

STAT

AUGUST 29, 2024

Hims & Hers, one of the largest publicly traded telehealth companies in the country, has supercharged its business in the last several months by offering compounded versions of the patented weight loss drugs known as GLP-1s. That has regularly been the case lately with GLP-1 drugs marketed by Novo Nordisk and Eli Lilly.  

Compounding 359

Compounding 359

STAT

OCTOBER 11, 2024

The Food and Drug Administration on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide, sold as Mounjaro for diabetes and Zepbound for obesity, from its shortage list, and, for the time being, would not pursue regulatory action against certain compounding pharmacies making copies of the drugs. 

Compounding Pharmacies 343

Compounding Pharmacies Compounding Diabetes 343

STAT

SEPTEMBER 21, 2024

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others.

Compounding 308

Compounding 308

STAT

OCTOBER 25, 2024

By law, that should have prohibited compound pharmacies from making copies of the drug, as they’re allowed to do so only when the treatment is on the shortage list.  The agency then made a sudden about-face , saying it would reconsider its decision and allow compounders to continue for the meantime.

Compounding Pharmacies 355

Compounding Pharmacies Compounding Diabetes 355

PharmaVoice

DECEMBER 11, 2024

The agency has yet to make a decision about keeping tirzepatide on or off of its shortage list — letting compound pharmacies continue their lucrative operations for now.

Compounding 162

Compounding Compounding Pharmacies 162

STAT

MARCH 3, 2025

The ad, asking patients to “be a healthy skeptic,” was released soon after a commercial from telehealth firm Hims & Hers, selling a compounded weight loss drug, premiered at the Super Bowl. Continue to STAT+ to read the full story…

Compounding 212

Compounding Documentation 212

STAT

FEBRUARY 6, 2025

Food and Drug Administration to “take action” against a “dangerous” ad that Hims & Hers plans to run during the Super Bowl promoting the use of compounded versions of GLP-1 drugs for combating obesity. “The commercial is misleading in its entirety,” the industry group wrote to the agency.

Compounding 264

Compounding 264

STAT

OCTOBER 10, 2024

Top of the morning to you and a fine one it is. Blue skies, cool breezes, and plenty of chirping birds are enveloping the comfy Pharmalot campus, which is cause to fire up the coffee kettle for yet another cup of stimulation. Our choice today is strawberry creme — sweets for the sweet, you know.

Compounding 257

Compounding 257

PharmaVoice

DECEMBER 5, 2022

GATC Health is driving a novel approach it believes could work for several major neurological conditions.

Compounding 262

Compounding 262

Compounding Pharmacy of America

DECEMBER 23, 2024

Learn how compounding pharmacies ensure safety and reliability through rigorous standards, sterile preparations, and personalized solutions for unique healthcare needs. The post Are Compounding Pharmacies Safe? Everything You Need to Know appeared first on Compounding Pharmacy of America.

Compounding Pharmacies 98

Compounding Pharmacies Compounding 98

BioPharma Dive

DECEMBER 2, 2024

The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that has gripped the FDA and compounding pharmacies over the past few months.

Compounding 121

Compounding Compounding Pharmacies Diabetes 121

STAT

JULY 20, 2023

The tornado that struck parts of North Carolina on Wednesday not only damaged the immediate area, but could soon make it much harder for countless people across the U.S. and around the world to obtain needed medicines the next time they visit a hospital. Among the damaged buildings was a Pfizer plant in Rocky Mountain, N.C. hospitals.

Compounding 246

Compounding Hospitals 246